403 related articles for article (PubMed ID: 16155021)
1. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
[TBL] [Abstract][Full Text] [Related]
2. Advances in the understanding of mantle cell lymphoma.
Jares P; Campo E
Br J Haematol; 2008 Jun; 142(2):149-65. PubMed ID: 18410453
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
[TBL] [Abstract][Full Text] [Related]
5. Update on the molecular biology of mantle cell lymphoma.
Bertoni F; Rinaldi A; Zucca E; Cavalli F
Hematol Oncol; 2006 Mar; 24(1):22-7. PubMed ID: 16402392
[TBL] [Abstract][Full Text] [Related]
6. Molecular control of the cell cycle in cancer: biological and clinical aspects.
Møller MB
Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
[TBL] [Abstract][Full Text] [Related]
7. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.
Jares P; Colomer D; Campo E
Nat Rev Cancer; 2007 Oct; 7(10):750-62. PubMed ID: 17891190
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies.
Obrador-Hevia A; Fernández de Mattos S; Villalonga P; Rodríguez J
Blood Rev; 2009 Sep; 23(5):205-16. PubMed ID: 19362399
[TBL] [Abstract][Full Text] [Related]
9. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
10. Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.
Medeiros LJ; Hai S; Thomazy VA; Estalilla OC; Romaguera J; Luthra R
Mod Pathol; 2002 May; 15(5):556-64. PubMed ID: 12011261
[TBL] [Abstract][Full Text] [Related]
11. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of mantle cell lymphoma: new perspectives and challenges with clinical implications.
Navarro A; Royo C; Hernández L; Jares P; Campo E
Semin Hematol; 2011 Jul; 48(3):155-65. PubMed ID: 21782057
[TBL] [Abstract][Full Text] [Related]
13. Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation.
Hutter G; Scheubner M; Ott G; Zimmermann Y; Hübler K; Roth S; Stilgenbauer S; Kalla J; Stöcklein H; Hiddemann W; Dreyling M
Ann Hematol; 2009 Sep; 88(9):821-8. PubMed ID: 19137297
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S
Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404
[TBL] [Abstract][Full Text] [Related]
15. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
Ott MM; Helbing A; Ott G; Bartek J; Fischer L; Dürr A; Kreipe H; Müller-Hermelink HK
J Pathol; 1996 Jul; 179(3):238-42. PubMed ID: 8774476
[TBL] [Abstract][Full Text] [Related]
16. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
Tucker CA; Bebb G; Klasa RJ; Chhanabhai M; Lestou V; Horsman DE; Gascoyne RD; Wiestner A; Masin D; Bally M; Williams ME
Leuk Res; 2006 Apr; 30(4):449-57. PubMed ID: 16183118
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.
Ek S; Björck E; Porwit-MacDonald A; Nordenskjöld M; Borrebaeck CA
Haematologica; 2004 Jun; 89(6):686-95. PubMed ID: 15194536
[TBL] [Abstract][Full Text] [Related]
18. Intranuclear expression of cyclin D1 protein as a useful prognostic marker for mantle cell lymphoma.
Hashimoto Y; Nakamura N; Kuze T; Abe M; Wakasa H
Fukushima J Med Sci; 1997 Dec; 43(2):87-98. PubMed ID: 9640844
[TBL] [Abstract][Full Text] [Related]
19. Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.
Kienle D; Katzenberger T; Ott G; Saupe D; Benner A; Kohlhammer H; Barth TF; Höller S; Kalla J; Rosenwald A; Müller-Hermelink HK; Möller P; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2007 Jul; 25(19):2770-7. PubMed ID: 17563396
[TBL] [Abstract][Full Text] [Related]
20. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
Espinet B; Salaverria I; Beà S; Ruiz-Xivillé N; Balagué O; Salido M; Costa D; Carreras J; Rodríguez-Vicente AE; Luís García J; Hernández-Rivas JM; Calasanz MJ; Siebert R; Ferrer A; Salar A; Carrió A; Polo N; García-Marco JA; Domingo A; González-Barca E; Romagosa V; Marugán I; López-Guillermo A; Millá F; Luís Mate J; Luño E; Sanzo C; Collado R; Oliver I; Monzó S; Palacín A; González T; Sant F; Salinas R; Ardanaz MT; Font L; Escoda L; Florensa L; Serrano S; Campo E; Solé F
Genes Chromosomes Cancer; 2010 May; 49(5):439-51. PubMed ID: 20143418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
